These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 34923022)

  • 21. Short-term strength and balance training does not improve quality of life but improves functional status in individuals with diabetic peripheral neuropathy: a randomised controlled trial.
    Venkataraman K; Tai BC; Khoo EYH; Tavintharan S; Chandran K; Hwang SW; Phua MSLA; Wee HL; Koh GCH; Tai ES
    Diabetologia; 2019 Dec; 62(12):2200-2210. PubMed ID: 31468106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping World Health Organization Quality of Life-BREF Onto 5-Level EQ-5D in Thai Patients With Chronic Diseases.
    Sakthong P
    Value Health; 2021 Aug; 24(8):1089-1094. PubMed ID: 34372973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
    Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
    PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between disease activity and quality of life in ulcerative colitis: Results from the CRONICA-UC study.
    Panés J; Domènech E; Aguas Peris M; Nos P; Riestra S; Juliá de Páramo B; Cea-Calvo L; Romero C; Marín-Jiménez I
    J Gastroenterol Hepatol; 2017 Nov; 32(11):1818-1824. PubMed ID: 28370253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discontinuously supervised aerobic training vs. physical activity promotion in the self-management of type 2 diabetes in older Italian patients: design and methods of the 'TRIPL-A' randomized controlled trial.
    Lucertini F; Ferri Marini C; Sisti D; Stocchi V; Federici A; Gregorio F; Piangerelli D; Chiatti C; Cherubini A; Boemi M; Romagnoli F; Cucchi M; D'Angelo F; Luconi MP; Bonfigli AR
    BMC Geriatr; 2019 Jan; 19(1):11. PubMed ID: 30634923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing the EQ-5D-5L crosswalks and value sets for England, the Netherlands and Spain: Exploring their impact on cost-utility results.
    Ben Â; Finch AP; van Dongen JM; de Wit M; van Dijk SEM; Snoek FJ; Adriaanse MC; van Tulder MW; Bosmans JE
    Health Econ; 2020 May; 29(5):640-651. PubMed ID: 32059078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimum important difference of the EQ-5D-5L and EQ-VAS in fibrotic interstitial lung disease.
    Tsai APY; Hur SA; Wong A; Safavi M; Assayag D; Johannson KA; Morisset J; Fell C; Fisher JH; Manganas H; Shapera S; Cox G; Gershon AS; Hambly N; Khalil N; To T; Wilcox PG; Halayko A; Kolb MR; Ryerson CJ
    Thorax; 2021 Jan; 76(1):37-43. PubMed ID: 33023996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
    Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
    Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychometric Properties of EQ-5D-3L and EQ-5D-5L in Cognitively Impaired Patients Living with Dementia.
    Michalowsky B; Hoffmann W; Xie F
    J Alzheimers Dis; 2021; 83(1):77-87. PubMed ID: 34275901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness.
    Bilbao A; García-Pérez L; Arenaza JC; García I; Ariza-Cardiel G; Trujillo-Martín E; Forjaz MJ; Martín-Fernández J
    Qual Life Res; 2018 Nov; 27(11):2897-2908. PubMed ID: 29978346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
    Martin A; Meads D; Griffiths AW; Surr CA
    Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study on the validity and psychometric properties of the electronic EQ-5D-5L in routine clinical practice.
    Lam CLK; Tse ETY; Wong CKH; Lam JSM; Chen SS; Bedford LE; Cheung JPY; Or CK; Kind P
    Health Qual Life Outcomes; 2021 Dec; 19(1):266. PubMed ID: 34922564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convergent validation of EQ-5D-5L in patients with Parkinson's disease.
    Alvarado-Bolaños A; Cervantes-Arriaga A; Rodríguez-Violante M; Llorens-Arenas R; Calderón-Fajardo H; Millán-Cepeda R; Leal-Ortega R; Estrada-Bellmann I; Zuñiga-Ramírez C
    J Neurol Sci; 2015 Nov; 358(1-2):53-7. PubMed ID: 26276513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the Quality of Life and Health-Related Quality of Life of Patients With End-Stage Kidney Disease Resulting From Kidney Transplantation Using the Kidney Disease Quality of Life-Short Form and EuroQOL-5 Dimension-5 Level Questionnaires.
    Sawada A; Hiragi S; Tamura H; Goto R; Matsuyama Y; Sakai K; Miyata H; Yanagita M; Kuroda T; Ogawa O; Kobayashi T
    Transplant Proc; 2021 Apr; 53(3):881-884. PubMed ID: 33303208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The added value of extending the EQ-5D-5L with an itching item for the assessment of health-related quality of life of burn patients: an explorative study.
    Spronk I; Bonsel GJ; Polinder S; van Baar ME; Janssen MF; Haagsma JA
    Burns; 2021 Jun; 47(4):873-879. PubMed ID: 33012569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.
    García-Gordillo M; del Pozo-Cruz B; Adsuar JC; Sánchez-Martínez FI; Abellán-Perpiñán JM
    Qual Life Res; 2014 May; 23(4):1315-26. PubMed ID: 24258254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supervised exercise training as an adjunctive therapy for venous leg ulcers: study protocol for a randomised controlled trial.
    Tew GA; Michaels J; Crank H; Middleton G; Gumber A; Klonizakis M
    Trials; 2015 Oct; 16():443. PubMed ID: 26445318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
    Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
    Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A (five-)level playing field for mental health conditions?: exploratory analysis of EQ-5D-5L-derived utility values.
    Camacho EM; Shields G; Lovell K; Coventry PA; Morrison AP; Davies LM
    Qual Life Res; 2018 Mar; 27(3):717-724. PubMed ID: 29248995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged "no-problems".
    Murasawa H; Sugiyama T; Matsuoka Y; Okabe T; Wakumoto Y; Tanaka N; Sugimoto M; Oyama M; Fujimoto K; Horie S; Funagoshi M; Arakawa I; Noto S; Shimozuma K
    Qual Life Res; 2020 Mar; 29(3):755-763. PubMed ID: 31583618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.